What increased health risks are associated with children conceived from cryopreserved (frozen) embryos?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Health Risks in Children Conceived from Frozen Embryos

Children conceived from frozen embryos face increased risks of being large for gestational age (LGA), macrosomia, and higher birth weight, with additional maternal risks including hypertensive disorders of pregnancy and postpartum hemorrhage—particularly when programmed (hormone replacement) cycles are used rather than natural ovulatory cycles.

Key Perinatal Risks

Increased Birth Weight and Size

  • Large for gestational age (LGA) occurs in approximately 30% of frozen embryo transfer (FET) pregnancies compared to 25% in fresh transfers 1, 2
  • Birth weight is elevated by an average of 127 grams in FET singletons 3
  • Macrosomia risk is significantly increased, particularly in programmed cycles (adjusted OR 1.62) 4

The mechanism appears related to the absence of corpus luteum in programmed cycles rather than cryopreservation itself, as natural cycle FET shows outcomes similar to fresh transfers 5.

Maternal Complications

Mothers carrying frozen embryo pregnancies face:

  • Hypertensive disorders of pregnancy (OR 2.15) 3
  • Postpartum hemorrhage (OR 2.63 in programmed cycles) 4
  • Placenta accreta spectrum disorders (increased in hormone replacement cycles) 5

Critical distinction: These risks are substantially higher with programmed/hormone replacement cycles compared to natural ovulatory cycle FET 4, 5. When corpus luteum is present (natural or stimulated cycles), outcomes approximate those of fresh transfers.

Epigenetic and Long-Term Concerns

Imprinting Disorders

There is evidence of increased risk of rare genomic imprinting disorders including:

  • Beckwith-Wiedemann syndrome
  • Silver-Russell syndrome
  • Prader-Willi syndrome

These conditions result from disruption of DNA methylation patterns during the cryopreservation process, as the epigenome is particularly vulnerable to cryoprotective agents 6.

Childhood Growth Patterns

  • Height Z-scores are elevated in children from frozen transfers, suggesting they grow taller 2
  • Body weight and BMI Z-scores show no significant differences through childhood 2

Protocol-Specific Risk Stratification

Highest Risk: Programmed (Hormone Replacement) Cycles

  • Postterm birth (OR 1.59-1.98)
  • Macrosomia (OR 1.40-1.62)
  • Hypertensive disorders (OR 1.61-1.78)
  • Postpartum hemorrhage (OR 2.63-2.87) 4

Lower Risk: Natural or Stimulated Ovulatory Cycles

  • Outcomes similar to fresh embryo transfer
  • Presence of corpus luteum appears protective 4, 5

Additional Risk Factor: Repeated Cryopreservation

Embryos frozen multiple times (re-vitrification) show:

  • Reduced clinical pregnancy rates (27% vs 45%, OR 0.48)
  • Reduced live birth rates (19% vs 38%, OR 0.35)
  • Effect most pronounced in women under 35 years 7

Outcomes Without Increased Risk

Reassuringly, several outcomes show no increased risk:

  • Preterm birth rates are comparable or lower than fresh transfers 3
  • Low birth weight is less common with FET 3
  • Congenital anomalies show no significant difference 7
  • Miscarriage rates are similar between strategies 3
  • OHSS risk is substantially reduced (OR 0.26) 3

Clinical Implications

When frozen embryo transfer is medically indicated:

  1. Prioritize natural or stimulated ovulatory cycles over programmed hormone replacement protocols when feasible 4, 5

  2. Avoid repeated cryopreservation in women under 35 years unless medically necessary 7

  3. Counsel patients specifically about:

    • 5-6% absolute increase in LGA risk
    • Doubled risk of hypertensive disorders
    • Potential for higher birth weight babies (average 127g increase)
    • These risks are protocol-dependent, not inherent to cryopreservation
  4. Enhanced monitoring during pregnancy for:

    • Blood pressure (screen for hypertensive disorders)
    • Fetal growth (ultrasound surveillance for macrosomia)
    • Postpartum hemorrhage preparedness

Important caveat: The evidence suggests the endometrial preparation method matters more than cryopreservation itself. The absence of corpus luteum in programmed cycles appears to be the primary driver of adverse outcomes 4, 5. This represents a modifiable risk factor through cycle selection.

Related Questions

What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
Based on my lab results (24‑hour urine output 1.7 L, urine osmolality 636 mOsm/kg after water restriction, serum osmolality 292 mOsm/kg, serum sodium 143 mmol/L, eGFR >90 mL/min/1.73 m²), do I have undiagnosed diabetes insipidus?
In a patient with flank pain and a positive urinalysis for urinary tract infection who is awaiting urine culture results, can I start empiric ciprofloxacin?
What ICD-10-CM codes should be used on a neurology referral for a patient with post-concussive syndrome, brain fog, and sleep disturbances?
What is the appropriate dosage, frequency, and duration for a warm honey‑lemon drink in a 16‑year‑old adolescent with cough, and when should an antitussive be considered?
What is the appropriate treatment for a distal phalanx tuft fracture of the fifth toe?
What does the most recent study recommend as gastric residual volume thresholds for nasogastric tube (NGT) and gastrostomy tube (G‑tube) feeding to minimize aspiration risk?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.